Lexicon Pharmaceuticals, Inc. (LXRX)
1.69
+0.09
(+5.62%)
USD |
NASDAQ |
May 07, 16:00
1.67
-0.02
(-1.18%)
After-Hours: 20:00
Lexicon Pharmaceuticals Research and Development Expense (Annual) : 60.50M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Viemed Healthcare, Inc. | 3.017M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Novavax, Inc. | 336.82M |
| Kura Oncology, Inc. | 251.07M |
| Liquidia Corp. | 38.45M |